Publications
26
Citations
16
Est. group size
—
Recurring co-author estimate
Active years
12
Publishing since 2015
Glenn Boyles is a gynecologic oncology researcher whose work focuses on endometrial (uterine) cancer, including clinical management, immune-related side effects of immunotherapy drugs like pembrolizumab, and laboratory studies of how dietary fatty acids and metabolism affect tumor growth. The research spans clinical outcomes studies, translational lab work on cancer cell biology, and surgical/quality-of-care topics in gynecologic cancer treatment.
Publication output was minimal or absent in the earlier part of the decade but has grown substantially in the most recent two years, with a notable surge in 2025 and 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Management of medically inoperable low-grade endometrial cancer: patterns of care and outcomes with radiation, brachytherapy, and hormonal therapy
International Journal of Gynecological Cancer · 2026
- Immune-Related Adverse Events Among Patients With Endometrial Cancer Receiving Pembrolizumab Alone or With Other Treatments: A Single-Center Real-World Experience
Journal of Immunotherapy · 2026
- Eicosapentaenoic Acid Suppresses Tumor Growth and Enhances Chemosensitivity via AKT/mTOR Signaling in Uterine Serous Carcinoma
Cancers · 2026
- Eicosapentaenoic Acid Suppresses Tumor Growth and Enhances Chemosensitivity via AKT/mTOR Signaling in Uterine Serous Carcinoma
UNC Libraries · 2026
- Eicosapentaenoic Acid Suppresses Tumor Growth and Enhances Chemosensitivity via AKT/mTOR Signaling in Uterine Serous Carcinoma.
UNC Libraries · 2026
- Abstract 1731: Combination therapy with onvansertib and carboplatin demonstrate anti-tumorigenic effects in endometrioid endometrial cancer cell lines
Cancer Research · 2025
- Abstract 1730: Onvansertib in combination with carboplatin demonstrates enhanced anti-tumorigenic effects in pre-clinical models of serous endometrial cancer
Cancer Research · 2025
- Immune-Related Adverse Events Among Patients with Endometrial Carcinoma: A Single-Center Real-World Experience
SSRN Electronic Journal · 2025
- Scholarly productivity during gynecologic oncology fellowship: A cross-sectional survey of graduates from 2020 to 2024
Gynecologic Oncology Reports · 2025
- Inter-relationship of race, the microbiome and the metabolome in endometrial cancer
Gynecologic Oncology · 2025
- Intermittent fasting in combination with progesterone as an effective treatment strategy in a mouse model of obesity-driven endometrial cancer
Gynecologic Oncology · 2025
- Antitumorigenic effects of docosahexaenoic acid in endometrial cancer cell lines
Gynecologic Oncology · 2025
- Trends in immune-related adverse events among patients with endometrial carcinoma
Gynecologic Oncology · 2025
- Uterine Sacculation With Entrapped Placenta After Delivery
Obstetrics and Gynecology · 2024
- Less is more: Abdominal closure protocol does not reduce surgical site infection after hysterectomy
Gynecologic Oncology · 2022
- Gynecologic Oncology×9
- Gynecologic Oncology Reports×3
- Cancer Research×2
- UNC Libraries×2
- BMJ Case Reports×1
- Quinn Kistenfeger
Medicine · The Ohio State University
- Allison Quick
Medicine · The Ohio State University
- Kristin Bixel
Medicine · The Ohio State University
- Corinne Calo
Medicine · The Ohio State University
- Larry J. Copeland
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile